Low-priced incentive system will hurt pharmaceutical sector

Published: 2009-12-22 07:00:00

Updated: 2009-12-22 07:00:00

Pharmaceutical business sources say Korea's pharmaceutical sector could lose a tremendous loss if the government’s plan to promote local hospitals to purchase low-priced medicines via a certain portion of incentive to a medical institution from July next year.

Aimed at providing cheaper drugs ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK